galimedix.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title Galimedix Therapeutics,
Description Galimedix is an ophthalmic pharmaceutical company developing truly novel and transformative treatments for several neurodegenerative
Keywords N/A
Server Information
WebSite galimedix favicongalimedix.com
Host IP 54.208.101.55
Location United States
Related Websites
Site Rank
More to Explore
galimedix.com Valuation
US$356,627
Last updated: 2023-05-06 23:03:02

galimedix.com has Semrush global rank of 29,678,939. galimedix.com has an estimated worth of US$ 356,627, based on its estimated Ads revenue. galimedix.com receives approximately 41,150 unique visitors each day. Its web server is located in United States, with IP address 54.208.101.55. According to SiteAdvisor, galimedix.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$356,627
Daily Ads Revenue US$330
Monthly Ads Revenue US$9,876
Yearly Ads Revenue US$118,510
Daily Unique Visitors 2,744
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
galimedix.com. A 1799 IP: 54.208.101.55
galimedix.com. A 1799 IP: 174.129.30.187
galimedix.com. NS 1800 NS Record: dns2.registrar-servers.com.
galimedix.com. NS 1800 NS Record: dns1.registrar-servers.com.
galimedix.com. MX 3600 MX Record: 0 galimedix-com.mail.protection.outlook.com.
galimedix.com. TXT 3600 TXT Record: v=spf1 include:spf.protection.outlook.com -all
galimedix.com. TXT 1800 TXT Record: MS=ms89315815
HtmlToTextCheckTime:2023-05-06 23:03:02
Home About Overview Strategy Management Team Board of Directors Products Technology Overview MOA Preclinical Experiments Glaucoma Preclinical Data AMD Preclinical Data Trigger Effect Superior Approach Neurorestoration Clinical Trials References News & Media Press Releases Presentations Posters Events In the News Videos Contact Treating the Leading Causes of Blindness and Alzheimer’s disease Galimedix Therapeutics is a Phase 2 neuropharmaceutical company developing novel first-in-class drugs with ground-breaking potential to slow or stop the progression of neurodegeneration and to improve function in glaucoma and dry AMD – leading causes of blindness – and also in Alzheimer’s disease. About Us A Potentially Disruptive Technology Galimedix Therapeutics is developing two unique small molecules GAL-101 and GAL-201 specifically to block a key underlying step in neurodegeneration: formation of toxic oligomers of amyloid beta (Aβ). These toxic Aβ oligomers have emerged as the central cause
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Tue, 26 Oct 2021 22:05:25 GMT
Server: Apache
Location: http://www.galimedix.com/
Content-Type: text/html; charset=UTF-8

HTTP/1.1 302 Moved Temporarily
Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Content-Type: text/html; charset=UTF-8
Date: Tue, 26 Oct 2021 22:05:25 GMT
Expires: Thu, 19 Nov 1981 08:52:00 GMT
Location: https://www.galimedix.com/
Pragma: no-cache
Server: Apache
Connection: keep-alive

HTTP/1.1 200 OK
Date: Tue, 26 Oct 2021 22:05:25 GMT
Server: Apache
Expires: Thu, 19 Nov 1981 08:52:00 GMT
Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Pragma: no-cache
Content-Type: text/html; charset=UTF-8
galimedix.com Whois Information
Domain Name: GALIMEDIX.COM
Registry Domain ID: 2235079176_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.namecheap.com
Registrar URL: http://www.namecheap.com
Updated Date: 2020-01-28T08:05:56Z
Creation Date: 2018-03-04T07:28:14Z
Registry Expiry Date: 2022-03-04T07:28:14Z
Registrar: NameCheap, Inc.
Registrar IANA ID: 1068
Registrar Abuse Contact Email: abuse@namecheap.com
Registrar Abuse Contact Phone: +1.6613102107
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: DNS1.REGISTRAR-SERVERS.COM
Name Server: DNS2.REGISTRAR-SERVERS.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-14T21:16:26Z <<<